Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis

Lupus

Volumn 18, Issue 2, 2009, Pages 149-158

  Schwartz, M M ^a   Korbet, S M ^a   Katz, R S ^a   Lewis, E J ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

Crescents; Diffuse global lupus GN; Glomerular necrosis; Lupus GN; Pathology; Prognosis; Segmental lupus GN

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLASSIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; GLOMERULUS; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PATHOLOGY; PLASMAPHERESIS; VASCULARIZATION;

ADULT; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; PLASMAPHERESIS; YOUNG ADULT;

EID: 65349169503     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203308095947     Document Type: Article

References (35)

1. Schwartz, MM, Roberts, JL, Lewis, EJ. Necrotizing glomerulitis of systemic lupus erythematosus. Hum Pathol 1983; 14: 158-167.
2. Schwartz, MM, Bernstein, J, Hill, GS, Holley, K, Phillips, EA. The Lupus Nephritis Collaborative Study Group. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int 1989; 36: 891-896.
3. Najafi, CC, Korbet, SM, Lewis, EJ, Schwartz, MM, Reichlin, M, Evans, J. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001; 59: 2156-2163.
4. Korbet, SM, Schwartz, MM, Evans, J, Lewis, EJ. Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244-254.
5. Churg, J, Sobin, LH. Lupus nephritis. Renal disease, classification and atlas of glomerular diseases. New York: Igaku-Shoin; 1982. p. 127-149.
6. Churg, J, Bernstein, J, Glassock, RJ. Lupus nephritis. renal disease. Classification and atlas of glomerular diseases. New York: Igaku-Shoin; 1995. p. 151-180.
7. Weening, JJ, D'Agati, VD, Schwartz, MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530.
8. Chang, A, Aneziokoro, O, Meehan, SM, Quigg, RJ. Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti-neutrophil cytoplasmic antibodies. Kidney Int 2007; 71: 360-365.
9. Marshall, S, Dressler, R, D'Agati, V. Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 1997; 29: 119-124.
10. Lewis, EJ, Hunsicker, LG, Rohde, RD, Lachin, JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med 1992; 326: 1373-1379.
11. Clough, JD, Lewis, EJ, Lachin, JM. Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Prog Clin Biol Res 1990; 337: 301-307.
12. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
13. Schwartz, MM, Lan, SP, Bonsib, SM, Gephardt, GN, Sharma, HM. and the Lupus Nephritis Collaborative Study Group. Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis. Am J Kidney Dis 1989; 13: 273-283.
14. Schwartz, MM, Korbet, SM, Lewis, EJ. The prognosis and pathogenesis of severe lupus glomerulonephritis. Nephrol Dial Transplant 2008; 23: 1298-1306.
15. Schwartz, MM, Lan, SP, Bernstein, J, Hill, GS, Holley, K, Lewis, EJ. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 1993; 21: 374-377.
16. Roberts, JL, Lewis, EJ. Identification of antinative DNA antibodies in cryoglobulinemic states. Am J Med 1978; 65: 437-445.
17. Reichlin, M. Measurements of antibodies to Sm and nRNP by ELISA: Clinical and serological correlations. In: Kasukawa, R, Sharp, GC, (eds), Tissue disease and autoantibodies. Amsterdam: Elsevier; 1987. p. 85-97.
18. Agresti, A. Categorical data analysis. New York: John Wiley; 1990.
19. Conover, WJ. Practical nonparametic statistics. New York: John Wiley; 1980.
20. Kalbfleisch, JD, Prentice, RL. The statistical analysis of failure time data. New York: John Wiley; 1980.
21. Hill, GS, Hinglais, N, Tron, F, Bach, JF. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med 1978; 64: 61-79.
22. Cameron, JS, Turner, DR, Ogg, CS, et al. Systemic lupus with nephritis: a long-term study. Q J Med 1979; 48: 1-24.
23. Jennette, JC. Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective. Am J Kidney Dis 1991; 18: 164-170.
24. Coll, E, Valles, M, Torguet, P, et al. Immunonegative necrotizing glomerulonephritis: an atypical case of lupus nephropathy. Nefrologia 2003; 23: 81-84 [Spanish].
25. Charney, DA, Nassar, G, Truong, L, Nadasdy, T. "Pauci-Immune" proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome. Am J Kidney Dis 2000; 35: 1193-1206.
26. Akhtar, M, al-Dalaan, A, el-Ramahi, KM. Pauci-immune necrotizing lupus nephritis: report of two cases. Am J Kidney Dis 1994; 23: 320-325.
27. Baldwin, DS, Gluck, MC, Lowenstein, J, Gallo, GR. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med 1977; 62: 12-30.
28. Dujovne, I, Pollak, VE, Pirani, CL, Dillard, MG. The distribution and character of glomerular deposits in systemic lupus erythematosus. Kidney Int 1972; 2: 33-50.
29. Appel, GB, Silva, FG, Pirani, CL, Meltzer, JI, Estes, D. Renal involvement in systemic lupus erythematosus (SLE): A study of fiftysix patients emphasizing histologic classification. Medicine 1978; 57: 371-410.
30. Sinniah, R, Feng, PH. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function. Clin Nephrol 1976; 6: 340-351.
31. Hill, GS, Delahousse, M, Nochy, D, Bariety, J. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int 2005; 68: 2288-2297.
32. Pradhan, VD, Badakere, SS, Bichile, LS, Almeida, AF. Antineutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India 2004; 52: 533-537.
33. Zhao, MH, Liu, N, Zhang, YK, Wang, HY. Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol Dial Transplant 1998; 13: 2821-2824.
34. Chin, HJ, Ahn, C, Lim, CS, et al. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 2000; 20: 57-63.
35. Chen, M, Yu, F, Wang, SX, Zou, WZ, Zhao, MH, Wang, HY. Antineutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol 2007; 18: 599-605.